Procyk R, Adamson L, Block M, Blombäck B
Thromb Res. 1985 Dec 15;40(6):833-52. doi: 10.1016/0049-3848(85)90320-2.
Fibrinogen and plasma fibronectin were shown to interact in the presence of factor XIIIa. The reaction was enhanced by dithiothreitol and was accompanied by an increase in the turbidity of the solution and the formation of particulate matter and gel structures. At a constant concentration of fibrinogen the turbidity increase was dependent on the fibronectin concentration and at a constant concentration of fibronectin, on the fibrinogen concentration. Kinetic experiments showed that an initial step in the reaction between fibrinogen and fibronectin was the formation of a transient intermediate containing 1 mole of fibrinogen and 1 mole of fibronectin. Transient intermediates of larger molecular weight and containing both fibrinogen and fibronectin were also formed. These heterooligomers eventually reached huge molecular sizes and at early times formed particulate matter that sedimented on centrifugation. The predominant molecular species formed in an equimolar mixture of fibrinogen and fibronectin were heteropolymers. Small amounts of homopolymers composed of fibrinogen and possibly also homopolymers of fibronectin were detected. The results are discussed in terms of reaction mechanism and potential importance of this novel oligomerization pathway in haemostasis, thrombosis and tissue repair.
研究表明,在因子ⅩⅢa存在的情况下,纤维蛋白原与血浆纤连蛋白会发生相互作用。二硫苏糖醇可增强该反应,同时溶液浊度增加,并伴有颗粒物和凝胶结构的形成。在纤维蛋白原浓度恒定的情况下,浊度增加取决于纤连蛋白的浓度;而在纤连蛋白浓度恒定的情况下,则取决于纤维蛋白原的浓度。动力学实验表明,纤维蛋白原与纤连蛋白反应的初始步骤是形成一种含有1摩尔纤维蛋白原和1摩尔纤连蛋白的瞬时中间体。还形成了分子量更大且同时含有纤维蛋白原和纤连蛋白的瞬时中间体。这些异源寡聚体最终达到巨大的分子尺寸,并在早期形成了离心时会沉淀的颗粒物。在纤维蛋白原和纤连蛋白的等摩尔混合物中形成的主要分子种类是异源聚合物。检测到少量由纤维蛋白原组成的同聚物以及可能的纤连蛋白同聚物。本文从反应机制以及这一新型寡聚化途径在止血、血栓形成和组织修复中的潜在重要性方面对结果进行了讨论。